Category Archives: Featured

Recent in: Featured

LANDMARK PARTNERSHIP PAVES WAY FOR CANADA’S FIRST RESEARCH FACILITY TO IMPROVE LYME DISEASE TESTING AND TREATMENT

New G. Magnotta Lyme Disease Research Lab to be Established at the University of Guelph; $1.4 Million Grant Awarded June 14, 2017 – GUEPLH, Ontario: The G. Magnotta Foundation for Vector-Borne Diseases has announced a $1.4 million grant over three years to the University of Guelph, Department of Molecular and Cellular Biology to undertake Canada’s first evidence-based translational medicine approach Continues →

Listen to today’s testimony of Dr. Ralph Hawkins, Dr. Liz Zubek, Canadian Blood Services and the Public Health Agency of Canada in the standing health committee.

June 8th, 2017 You can listen to the interesting testimony here… Dr. Njoo from the Public Health Agency of Canada believes patients are too stupid to be equal partners in setting guidelines on diagnostics and treatment.  Only his buddies at AMMI, IDSA and the US CDC are qualified to have the final say… the same group who have failed us Continues →

New York Times: More Than 80 Percent of Patient Groups Accept Drug Industry Funds, Study Shows

[CanLyme Note: We have been approached by various pharma industry to work with them but we have steadfastly refused in order to maintain our independence, so as to not be beholding to the for-profit industry.  Now if government and the Canadian medical associations and societies could shake their relationship with big-pharma then perhaps better health care would result.] March 2nd, 2017 Continues →

Canadian tax payer funded Lyme research not good value for dollar

In December of 2016 a Canadian article was published in PLOS ONE proporting itself as a good systematic review about Lyme disease testing accuracy. CanLyme has been trying to work closely with government on the value of good science as good evidence yet once again the government of Canada has managed to publish low-quality material without any patient expert input into Continues →

Medical community failing Lyme patients, Calgary doctor says

Elizabeth Payne, Ottawa Citizien, May 16th, 2016 Canada’s medical establishment came under pressure at a national conference into Lyme disease Monday, with a Calgary doctor suggesting treatment of some patients contravenes the Canadian Medical Association’s code of ethics. “We, as the medical community in Canada, are failing our patients,” said Dr. Ralph Hawkins, a Calgary physician who acknowledged his views Continues →

Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime

Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA http://dx.doi.org/10.3389/fmicb.2016.00062  10 February 2016 Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. While the majority of Lyme disease patients can resolve their symptoms if treated promptly, 10–20% of patients suffer from prolonged symptoms Continues →

The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease

Abstract Clinical practice guidelines are increasing in number. Unfortunately, when scientific evidence is uncertain, limited, or evolving, as is often the case, conflict often arises between guideline committees and practicing physicians, who bear the direct responsibility for the care of individual patients. The 2006 Infectious Diseases Society of America guidelines for Lyme disease, which have limited scientific support, could, if Continues →

Unravelling the mystery of Lyme disease: Why Canada needs to do more

Rian Michelsen is a rising star. Fifteen years ago, he was the toddler who burst out from behind the curtains singing Elvis’ Viva Las Vegas. As a young boy, he played the lead role in Oliver in his birthplace of Bermuda, before moving with his family to Toronto five years ago. Now, as a 17 year-old high school student, he’s Continues →

The association between infectious burden and Parkinson’s disease: A case-control study

Abstract   Introduction The etiology of Parkinson’s disease (PD) remains unclear. The aim of this study was to examine the association between common pathogenic infections and PD. Methods Antibody titers to common infectious pathogens including cytomegalovirus (CMV), Epstein Barr virus (EBV), herpes simplex virus type-1 (HSV-1), Borrelia burgdorferi (B. burgdorferi), Chlamydophila pneumoniae (C. pneumoniae) andHelicobacter pylori (H. pylori) were measured by Continues →

Press Release: CROSS CANADA BIKE RIDE FOR LYME DISEASE

St. CATHARINES, ON – APRIL 15, 2015 – At sunrise on May 11, 2015, Niagara natives, 22 year old Daniel Corso and his long time friend Tanner Cookson will begin their 8000 km bike ride across Canada to bring awareness to, and raise money for, Lyme disease. The ride begins in Victoria, BC at the Terry Fox “Mile 0” mark Continues →

Lyme and associated tick-borne diseases: global challenges in the context of a public health threat

Christian Perronne  c.perronne@rpc.aphp.fr Lyme disease, caused by Borrelia burgdorferi and transmitted by ticks, was initially considered a recent, rare and regional occurrence. We now have evidence that very similar bacteria infected humans in Europe during the ice age (Keller et al.,2012). Evidence-based data are scarce therefore many aspects of the disease remain controversial (Auwaerter et al.,2011; Lee and Vielmeyer, 2011; Perronne,2012), but in 2013 the Centers Continues →

TOUCHED BY LYME: CDC fires another salvo against “chronic Lyme”

[CanLyme note: There are no human tests for many of the borrelia species of bacteria that cause Lyme disease, yet they have perhaps convinced this poor gentleman he did not have Lyme disease. There is nothing in what they have reported that would rule out Lyme disease… so why is a government agency so willing to mislead the public? So Continues →